Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-069874

Options or other derivatives

  • Director acquired 46,359 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Phillips Gary M. Director 2024-06-04 Grant or award · Stock Option (Right to Buy) +40,282 40,282 D
Phillips Gary M. Director 2024-06-04 Grant or award · Stock Option (Right to Buy) +3,473 3,473 D
Phillips Gary M. Director 2024-06-04 Grant or award · Stock Option (Right to Buy) +2,604 2,604 D
Loading xslF345X05/ownership.xml…